Cannabis Use in Germany Before and After Partial Legalization

Cannabis use in Germany rose from 4.6% in 2012 to 9.8% in 2024, but the increase since partial legalization was small and not statistically significant.

Hoch, Eva et al.·Deutsches Arzteblatt international·2025·Moderate Evidencecross-sectional survey
RTHC-06669Cross Sectional surveyModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
cross-sectional survey
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Past-12-month cannabis use prevalence reached 9.8% in 2024 after partial legalization, up from 8.8% in 2021, but this difference was not statistically significant. The upward trend had been ongoing since 2012.

Key Numbers

Prevalence rose from 4.6% (2012) to 6.1% (2015) to 7.1% (2018) to 8.8% (2021) to 9.8% (2024). Most users consumed marijuana (92.3%) as joints (88.6%). Top motivations: getting high or having fun (66.8%) and stress relief (61.3%). 25.7% of users belonged to a cannabis social club.

How They Did This

Repeated cross-sectional surveys (Epidemiological Survey of Substance Abuse) across five waves from 2012 to 2024, with sample sizes ranging from 7,534 to 9,267 German-speaking adults per wave.

Why This Research Matters

Germany is one of the largest countries to partially legalize recreational cannabis, making early post-legalization data valuable for understanding whether policy changes accelerate existing consumption trends.

The Bigger Picture

Early evidence from multiple jurisdictions suggests legalization does not produce dramatic spikes in use, though modest increases appear over time. The German data aligns with patterns seen in North American legalization.

What This Study Doesn't Tell Us

The 2024 survey occurred very shortly after legalization (April 2024), limiting the ability to detect effects. Self-reported data may underestimate use. The 2024 wave had a smaller sample size than previous waves.

Questions This Raises

  • ?Will cannabis use in Germany continue to climb in subsequent years?
  • ?How will cannabis social clubs shape consumption patterns compared to commercial retail models?

Trust & Context

Key Stat:
9.8% of German adults reported past-year cannabis use in 2024, up from 4.6% in 2012
Evidence Grade:
Large nationally representative repeated cross-sectional surveys with consistent methodology across waves, though self-report and the short post-legalization window limit causal conclusions.
Study Age:
2025 publication analyzing 2024 post-legalization data from Germany.
Original Title:
Cannabis Consumption Before and After Partial Legalization in Germany: Early Trends, Consumption Patterns, and Motives.
Published In:
Deutsches Arzteblatt international, 122(23), 632-637 (2025)
Database ID:
RTHC-06669

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-06669·https://rethinkthc.com/research/RTHC-06669

APA

Hoch, Eva; Krowartz, Eva-Maria; Hollweck, Regina; Möckl, Justin; Olderbak, Sally. (2025). Cannabis Consumption Before and After Partial Legalization in Germany: Early Trends, Consumption Patterns, and Motives.. Deutsches Arzteblatt international, 122(23), 632-637. https://doi.org/10.3238/arztebl.m2025.0161

MLA

Hoch, Eva, et al. "Cannabis Consumption Before and After Partial Legalization in Germany: Early Trends, Consumption Patterns, and Motives.." Deutsches Arzteblatt international, 2025. https://doi.org/10.3238/arztebl.m2025.0161

RethinkTHC

RethinkTHC Research Database. "Cannabis Consumption Before and After Partial Legalization i..." RTHC-06669. Retrieved from https://rethinkthc.com/research/hoch-2025-cannabis-consumption-before-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.